New Jersey's Merck Names New President of Vaccines Business
By Susan Todd/The Star-Ledger
December 21, 2009, 11:46AM
Merck announced this morning that Julie Gerberding, who served as director of the Centers for Disease Control and Prevention until earlier this year, will head the drug maker’s vaccine business. Gerberding will lead the company’s $5 billion global vaccine business.
She will be responsible for the commercialization of the current portfolio of vaccines, which includes Zostavax for protection against shingles and Gardasil for prevention against human papillomavirus. She will also plan for the introduction of vaccines from the company’s pipeline and accelerating its efforts to broaden access to the developing world.
And from Reuters:
Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia.
She may be charged with reigniting flagging sales of Merck's Gardasil vaccine to prevent cervical cancer by protecting against human papillomavirus or HPV. After an encouraging launch Gardasil sales have been falling and were down 22 percent in the third quarter at $311 million.
By Susan Todd/The Star-Ledger
December 21, 2009, 11:46AM
Merck announced this morning that Julie Gerberding, who served as director of the Centers for Disease Control and Prevention until earlier this year, will head the drug maker’s vaccine business. Gerberding will lead the company’s $5 billion global vaccine business.
She will be responsible for the commercialization of the current portfolio of vaccines, which includes Zostavax for protection against shingles and Gardasil for prevention against human papillomavirus. She will also plan for the introduction of vaccines from the company’s pipeline and accelerating its efforts to broaden access to the developing world.
And from Reuters:
Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia.
She may be charged with reigniting flagging sales of Merck's Gardasil vaccine to prevent cervical cancer by protecting against human papillomavirus or HPV. After an encouraging launch Gardasil sales have been falling and were down 22 percent in the third quarter at $311 million.











Follow Mothering